Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bentley Pharmaceuticals, Inc.
Bentley Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
March 29th, 2008
Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, reported financial results for the fourth quarter and year ended December 31, 2007. Fourth quarter 2007 revenues were $34.8 million, a 29% increase (16% in constant currency) from $27.1 million reported in the fourth quarter of 2006. Gross margins on net product sales for the quarters ended December 31, 2007 and 2006 were 43.1% and 48.7%, respectively. The Company noted that reduced margins resulted from the implementation of price reductions by the Spanish government on March 1, 2007. Operating income for the fourth quarter 2007 was $0.9 million compared with $2.9 million reported in the...
Source: Law & Health Weekly (2008-03-29)
|
